Posted on 1月 8, 20251/8/25
The Evolution of Digital Health Policy: A 2024 Retrospective and 2025 Outlook
Posted on 12月 2, 202412/2/24
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer
Posted on 10月 2, 202410/2/24
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Posted on 9月 27, 20249/27/24
Digital Therapeutics: A Necessity for Italy – Insights from Roberto Ascione and Alberta Spreafico
Posted on 9月 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on 8月 21, 20248/21/24
EVERSANA Experts On-Stage at Frontiers Health 2024
Posted on 8月 2, 20248/2/24
EVERSANA’s Commitment to Health Innovation in Europe: Leading the Charge at Frontiers Health 2024
Posted on 7月 22, 20247/22/24
PDURS Explained: The FDA’s New Framework for Adding Software to Drug Labels
Posted on 5月 13, 20245/13/24
Demystifying the New Prescription Drug Use-Related Software Framework
Posted on 3月 7, 20243/7/24